Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined modality therapy.

C J McGinn1, T J Kinsella

  • 1Department of Human Oncology, University of Wisconsin Clinical Cancer Center, Madison 53792.

Current Opinion in Oncology
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of Successful and Probationary Football Officials.

The Physician and sportsmedicine·2016
Same author

An Immobilization Apparatus for the Chest.

Transactions of the American Climatological and Clinical Association. American Climatological and Clinical Association·2011
Same author

Surgical treatment of bronchiectasis.

Minnesota medicine·2010
Same author

Carcinoma of the esophagus.

Minnesota medicine·2010
Same author

Traumatic rupture of the bronchus.

The Journal of thoracic surgery·2010
Same author

Modern treatment of empyema.

Minnesota medicine·2010
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Chemoradiotherapy shows promising survival benefits for inoperable non-small cell lung cancer and high-risk rectal cancer patients. It also improves local control for limited-stage small cell lung cancer and esophageal cancers, with manageable toxicity.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Chemoradiotherapy combines chemotherapy and radiation therapy to treat various cancers.
  • Advances in treatment strategies are crucial for improving patient outcomes.
  • Understanding the efficacy and toxicity of combined-modality treatments is essential.

Purpose of the Study:

  • To review current literature on chemoradiotherapy advances in common malignancies.
  • To highlight survival advantages and improved local control achieved with chemoradiotherapy.
  • To discuss the additional toxicity associated with these treatment approaches.

Main Methods:

  • Literature review of published studies on chemoradiotherapy.
  • Analysis of preliminary randomized trials.

Related Experiment Videos

  • Evaluation of data on local control and survival rates.
  • Assessment of treatment-related toxicity.

    • Main Results:

    • Chemoradiotherapy demonstrates a survival advantage in inoperable non-small cell lung cancer.
    • Patients with high-risk rectal cancer show improved survival with chemoradiotherapy.
    • Concurrent chemoradiotherapy enhances local control in limited-stage small cell lung cancer.
    • Esophageal malignancies may also benefit from improved local control with chemoradiotherapy.

    Conclusions:

    • Chemoradiotherapy is an effective strategy for several common malignancies.
    • The combination therapy offers survival benefits and improved local control.
    • Careful consideration of additional toxicity is necessary for patient management.